MACH7 TECHNOLOGIES LIMITED — Capital/Financing Update 2023

Jul 20, 2023

==> picture [116 x 29] intentionally omitted <==

ASX Announcement

21 July 2023

DIAGNOSTIC IMAGING ASSOCIATES DIALS UP VOLUME IN NEW $3.7M CONTRACT

• Mach7 signs 5 year subscription licence to provide eUnity to Diagnostic Imaging Associates (DIA)

• Full spectrum contract replaces small use case Client Outlook mammography contract

• A$3.7 million[1] TCV[2] will add A$0.64 million to Annual Recurring Revenue (ARR)

• Further expands Mach7’s footprint in the outpatient/teleradiology marketplace

Mach7 Technologies Limited (“Mach7” or the “Company”) (ASX:M7T), a company specialising in innovative medical imaging software solutions, is pleased to announce it has signed a new five year licence agreement with Diagnostic Imaging Associates. As part of the contract, Mach7 will provide its eUnity Diagnostic Viewer solution to DIA for general diagnostic interpretation and mammography diagnostic reading.

Based on a subscription licensing model, the contract expands the use of eUnity beyond an original 75,000 annual study agreement for mammography remote reading to a licence covering the full spectrum of eUnity’s diagnostic tools for 1.2 million studies annually, a 16-fold volume increase. The new contract has a TCV of A$3.7 million and will add A$0.64 million to ARR.

CEO and Managing Director of Mach7, Mike Lampron said “Market research continues to evidence a dynamic shift in where and how patients want to receive healthcare. This is amplified by the tightening of reimbursement rules by North American payers for non-emergency imaging due to the additional price tag placed on imaging by acute care providers. DIA represents a large, growing practice that is benefiting from the shift in diagnostic imaging from acute care to ambulatory settings and we are delighted to now provide its 70-strong radiologist practice with the full functionality of our zero-footprint eUnity Diagnostic Viewer.”

About DIA:

Diagnostic Imaging Associates was established in 1971 to provide quality radiology services to a local hospital in Tulsa, Oklahoma. Since then it has rapidly developed into a high-value onsite and teleradiology service provider to both public and private radiology departments throughout Oklahoma and the surrounding states. DIA is a physician owned organisation focused on great customer service and outstanding patient care.

1 Exchange rate: AUD/USD = $0.68; All values expressed in Australian dollars unless otherwise stated

2 Total Contract Value

Released on authority of the Board by:

Mike Lampron Managing Director and Chief Executive Officer

For more information, contact:

Rebecca Thompson Head of Investor Relations Mach7 Technologies Limited +61 (0) 416 079 329 Rebecca.Thompson@mach7t.com

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organisations. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing enterprise Data Management, Enterprise Diagnostic Viewing and Diagnostic Workflow applications. Mach7’s Enterprise Data Management solution, consisting of a powerful Vendor Neutral Archive (VNA) and data administration tools, allows for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the Cloud. In July 2020, Mach7 acquired Client Outlook and the eUnity Enterprise Diagnostic Viewing technology to augment Mach7’s Enterprise Data Management and Diagnostic Workflow applications. eUnity is a zero-footprint, FDA-approved, image viewing solution that makes images accessible on any workstation. This offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. Uniquely, the company also gives customers independence to deploy its solutions either on a component basis or in a unified comprehensive platform. Mach7 has built a global network of diverse customers that range from expansive Integrated Delivery Networks, National Health Systems, medical research facilities, and large academic medical institutions to regional community hospitals, private radiology practices, and independent provider groups. Visit Mach7t.com.

==> picture [206 x 72] intentionally omitted <==

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: 03 9692 7222 www.mach7t.com